Here are four micro-stories showcasing how our clients are safely and effectively unlocking value from structured and unstructured data.
Here are seven micro-stories showcasing how our clients are safely and effectively unlocking value from structured and unstructured data.
Privacy Analytics’ Redaction-as-a-Service ensures fast, cost-effective clinical trial document submissions at scale
We believe that data-driven insights are critical to addressing challenges introduced by the current pandemic, and that benefits can be realized while respecting privacy.
I wrote in our September newsletter about how trial sponsors are well advised to view transparency as much more than just a box that has to be checked off.
Clinical trial transparency can build stakeholder trust and drive real value – but patient privacy must be protected. Read on to learn how.
Just over a year ago, Health Canada stipulated that all clinical trials documents needed to make their way onto its designated portal.
Privacy Analytics is wholly committed to the global effort to respond to COVID-19.
Compliance is important, and the first step for many transparency programs needing to satisfy EMA Policy 0070 and new Health Canada guidance.
Should sponsors integrate risk-based anonymization across both documents and structured individual patient data (S-IPD)?
Unstructured data, such as medical notes, pose unique challenges with regards to anonymization.
Health Canada has introduced new regulatory guidance for anonymizing clinical study reports.
Event: Privacy Analytics’ Executive Round Table on the Future of Clinical Trials Data Sharing, September 18, 2018, London, England
Privacy Analytics is pleased to partner with Vivli: a new, groundbreaking digital platform where researchers can request and analyze clinical trial data...
Filter by Data Type
Categories
